Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma

Yu Zhi-jian; Meng Xian-yong; Xu Ke-cheng; Ge Zheng-ju

doi:10.1007/BF02942930

Your Location：

Home >

Browse articles >

Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma

Updated：2021-08-27

- Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma
- Chinese Journal of Integrative Medicine Vol. 1, Issue 3, Pages: 175-178(1995)
- Affiliations：
  
  Digestive Disease Research Section, Affiliated Hospital of Nantong Medical College,Nantong
- Author bio：
- Funds：
- DOI：10.1007/BF02942930
  CLC：
- Published：1995，
Scan for full text
Yu, Zj., Meng, Xy., Xu, Kc. et al. Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma., CJIM 1, 175–178 (1995). https://doi.org/10.1007/BF02942930

Yu Zhi-jian, Meng Xian-yong, Xu Ke-cheng, et al. Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma. [J]. Chinese Journal of Integrative Medicine 1(3):175-178(1995)
Yu, Zj., Meng, Xy., Xu, Kc. et al. Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma., CJIM 1, 175–178 (1995). https://doi.org/10.1007/BF02942930 DOI：

Yu Zhi-jian, Meng Xian-yong, Xu Ke-cheng, et al. Hydroxycamptothecine and cantharidin combined with cisplatin and lipiodol through transcatheter arterial embolization in hepatocellular carcinoma. [J]. Chinese Journal of Integrative Medicine 1(3):175-178(1995) DOI： 10.1007/BF02942930.

摘要

Transcatheter arterial embolization with hydroxycamptothecine

cantharidin and cisplatin

thoroughly mixed with large doses of interferon and interleukin-2

was performed in 48 cases with unresectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remission rate of 54.2%

significantly higher than that in embolization with chemotherapeutic agents alone (cisplatin

adriamycin and mitomycin

32.1%

P<0.01). Morever

the adverse reactions of hydroxycamptothecine and cantharidin

when applied systemically

including hematuria or urodynia were successfully eliminated.

Abstract

Transcatheter arterial embolization with hydroxycamptothecine

cantharidin and cisplatin

thoroughly mixed with large doses of interferon and interleukin-2

was performed in 48 cases with unresectable intermediate or advanced hepatocellular carcinoma. The results demonstrate a partial remission rate of 54.2%

significantly higher than that in embolization with chemotherapeutic agents alone (cisplatin

adriamycin and mitomycin

32.1%

P<0.01). Morever

the adverse reactions of hydroxycamptothecine and cantharidin

when applied systemically

including hematuria or urodynia were successfully eliminated.

关键词

hydroxycamptothecinecantharidinhepatocellular carcinomatranscatheter arterial embolization

Keywords

hydroxycamptothecinecantharidinhepatocellular carcinomatranscatheter arterial embolization

references

1977; 8:31.

1983; 1:22.

1992; 11:2.

1990:7–9

1974; 3:207.

1981; 1:35.

1990:244–246.

1990; 16:10.

Ikeda K, et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: An analysis by the Cox proportional hazard model. Cancer 1991; 68(10):2150.

Brimm EA, et al. Lymphokine-activated killer cell phenomenon; lysis of natural killer-resistant fresh tumor cells by IL-2 activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155:1823.

FULL TEXT LINK

More>

Views

697

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Bear bile powder (熊胆粉) induces apoptosis of human hepatocellular carcinoma cells via mitochondrion-dependent pathway

Preventive effects of Jiedu Granules (解毒颗粒) combined with Cinobufacini Injection (华蟾素注射液) versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: A case-control trial

Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine

Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells

Oxysophoridine suppresses the growth of hepatocellular carcinoma in mice: In Vivo and cDNA microarray studies

Related Author

No data

Related Institution

Fujian Guizhentang Pharmaceutical Co., Ltd.

Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine

Fujian Academy of Integrative Medicine

Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University

Faculties of Pharmacy and Medicine, University of Manitoba, Manitoba

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰